Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Improved Accuracy for Localization of Radiotherapy Treatment to Drive the Demand for Fiducial Markers
save 25 %
* Required Fields
Pay by invoice
15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease management. Radiotherapy is used in cancers that are localized; it can provide excellent control with no recurrence in the treated area. Radiotherapy is also frequently used in combination with surgery or with chemotherapy. As radiotherapy is a more cost-effective cancer treatment modality, expanding the services of radiotherapy is necessary to providing effective treatment strategies for cancer across care settings. Delivery of radiotherapy with high accuracy and precision—to reduce injury to normal tissues—is the need of the hour. Fiducial markers enable providers to accurately locate tumor lesions and deliver localized and targeted radiotherapy with higher accuracy. Implantation of gold fiducial markers is a cost-effective method. Complications from fiducial marker implantation are not common. Migration of implanted markers is rare and clinically insignificant. Fiducial markers are now considered the standard of care in the delivery of modern prostate RT, and their use is recommended, especially at dose escalation. Fiducials are an excellent surrogate for prostate position and allow for accurate treatment delivery and minimize the effect of radiation on surrounding organs. The main purpose of using fiducial markers is to increase treatment precision where tracking a tumor is difficult. Fiducial markers are commonly used in prostate and lung cancer and are still in the early stages of being used in the treatment of breast, liver and pancreatic cancer.Lack of clarity on reimbursement, patient selection, lack of training and skill set, and adoption of CBCT are the main challenges to widespread adoption of fiducial markers. On the other hand, easy implantation, low cost, potential for use in future diagnostic purpose, and well-established clinical evidence serve as major driving factors. The research service provides an end-user and market perspective for the use of fiducial markers in US and Europe and provides a five-year forecast from 2017 to 2022. The unique value of this study is that it provides insights gathered from more than 150 end users, including oncologists, interventional radiologists, radiation oncologists, urologists, and pulmonologists. The key applications covered in the report include breast cancer, liver cancer, prostate cancer, lung cancer, and pancreatic cancer. In depth analysis is provided for prostate and lung cancer.Author: Sowmya Rajagopalan
Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies
Global Connected Medical Devices Growth Opportunities
Technological Advances in RNA Stabilization & Delivery
GROWTH OPPORTUNITIES IN mRNA THERAPEUTICS, GENOMICS PLATFORMS, MICROBIOME TESTING, WOULD HEALING SOLUTIONS, AND AI-BASED DIAGNOSTICS
Global Medtech Mergers and Acquisitions (M&As) Growth Opportunities
Growth Opportunities in Global Electrophysiology Devices
Frost Radar™: Global Negative Pressure Wound Therapy Technology Devices, 2021
Frost Radar™: Global RNA Delivery Technologies, 2021
US Value-based Care: Trends & Business Implications for Medical Device Companies
INNOVATIONS AND GROWTH OPPORTUNITIES IN MEDICAL IMAGING, WEARABLE MEDICAL DEVICES, AND OPHTHALMIC SOLUTIONS
activated carbon market
food waste market
consumer drone market
smart home market
video analytics market
plastic waste management market
flexible packaging market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.